Additional Information

Description

Warfarin Sodium 5 mg tablets are anticoagulant medications used to prevent and treat blood clots. They are prescribed for conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), and stroke prevention in individuals with atrial fibrillation or mechanical heart valves. By reducing the blood's ability to form clots, warfarin minimizes the risk of potentially life-threatening complications associated with clotting disorders.

The primary mechanism of action involves inhibiting the synthesis of vitamin K-dependent clotting factors II, VII, IX, and X, as well as proteins C and S. This inhibition interferes with the coagulation cascade, preventing the formation and growth of blood clots. The anticoagulant effect develops gradually, typically taking 24-72 hours for measurable impact and reaching full therapeutic effect within 5-7 days.

Warfarin Sodium 5 mg tablets are administered orally, with dosage individualized based on the patient's International Normalized Ratio (INR) and clinical response. Regular INR monitoring is critical to ensure the appropriate balance between preventing clot formation and minimizing the risk of bleeding. Side effects may include bleeding, bruising, and, in rare cases, skin necrosis or hypersensitivity reactions.